Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Todd D. Shuster"'
Autor:
Richard A. Oberfield, Veronica Triaca, Leonard Zinman, Todd D. Shuster, Robert S. Hanley, Brian Billmeyer, Lyubov Girshovich, Michael S. Cohen
Publikováno v:
The Journal of urology. 179(2)
We evaluated the efficacy of a combined chemoradiation therapy protocol for the primary treatment of primary invasive carcinoma of the male urethra.From January 1991 to December 2006, 18 patients with invasive carcinoma of the male urethra referred t
Autor:
Satish, Sivasankaran, Anthony T, Sonn, David M, Venesy, Sherif B, Labib, Bruce S, Tronic, Todd D, Shuster, Sergio, Waxman
Publikováno v:
Texas Heart Institute journal. 34(1)
Autor:
Neela Natarajan, Todd D. Shuster
Publikováno v:
The Surgical clinics of North America. 86(4)
There has been a dramatic improvement in outcomes for patients who have colon cancer over recent years. These improvements have come about largely because of the availability of new chemotherapy agents (irinotecan, oxaliplatin and capecitabine) and n
Autor:
Glenn J. Bubley, Yoo-Joung Ko, Todd D. Shuster, Daniel E. Morganstern, Barur R. Rajeshkumar, Mary-Ellen Taplin
Publikováno v:
Seminars in oncology. 28(4 Suppl 15)
Over the past 10 years, men with prostate cancer have received earlier diagnoses and are undergoing prostatectomy and/or radiation therapy with curative intent; however, many men have increasing prostate-specific antigen (PSA) levels without evidence
Publikováno v:
The Surgical clinics of North America. 80(2)
In 1999, approximately 180,000 new cases of breast cancer will occur in the United States. 65 Although mortality rates decreased an average of 1.7% per year from 1990 to 1995, the 45,000 breast cancer deaths in 1999 represent 16% of deaths caused by
Publikováno v:
Journal of Clinical Oncology. 25:1138-1139
Autor:
Todd D. Shuster, Amy E. Spooner, Glenn J. Bubley, Steven P. Balk, Harold N. Keer, Mary-Ellen Taplin, George K. Ogata, Martha E. Frantz
Publikováno v:
The New England journal of medicine. 332(21)
Metastatic prostate cancer is a leading cause of cancer-related death in men. The rate of response to androgen ablation is high, but most patients relapse as a result of the outgrowth of androgen-independent tumor cells. The androgen receptor, which
Autor:
Todd D. Shuster, Leonard Zinman, Lyubov Girshovich, Richard A. Oberfield, Veronica Triaca, Brian Billmeyer
Publikováno v:
Journal of Urology. 173:121-121
Autor:
Dawn M. Santora, Melissa McNeil, Mark D. Gulinson, Lisa A. Marr, Erol M. Kosar, Richard H. Hunn, Robert J. Pritchard, Jill Wachman, Richard P. Lofgren, Joseph L. Lipinski, Stephen G. Rohn, Joseph Conigliaro, Karen E. Caldwell, Ruth Ann Guilinger, Abraham Thomas, Karl E. Bushman, Thomas Dinella, Jennifer Hartle, Michael W. Finikiotis, Timothy M. Hunter, Richard C. Hogan, Carol J. Higham, Jill, Leighton J. Sweet, Thomas I. Murtaugh, John J. Szawaluk, David S. Macpherson, Edward G. Dianesi, Samuel I. Hammerman, Laurie M. Hankin, Mariellen T. Rodman, Jennifer L. Osborn, David M. Friedland, Edward J. Schloss, Robert J. Leon, Coleen M. Andruss, William J. Pendergast, Virginia Balderston, Marc I. Sandberg, Robert G. Finkel, Janet M. Hines, Caroline J. Lubick, Alan R. Stein, Sander van Cleeff, Lawrence C. Reardon, Michele A. Young, Anita Deswal, Mark E. Collins, David S. Richards, Todd D. Shuster, Robert J. Hally, Rosemarie A. Leuzzi, Erika L. Hoffman, Donna C. Needleman, Steven E. Labkoff, Lisa C. Ramsey, Michael A. McGuiness, Thomas J. Dinella, Steven T. Tee, Anthony P. Pietropaoli, Colleen M. Andruss, David A. Nace, Thomas A. Selvaggi, Mitchell G. Cohen, Emily L. Yee, Robert K. Zeldin, Laurance W. Kam, Kevin J. McCullum, Steven Lilie, James V. Harris, Kathleen J. Keyes, Lana Tsao, Michael S. Heinle, Caroline G. Dale, Glenn C. Michelson, C. Bernie Good, Julia M. Dippl, Mark A. Provensano, Robert S. Gorby, Daniel J. O'Rourke, Mary L. Cameron, Jeff Whittle
Publikováno v:
Archives of Internal Medicine. 155:389
Background: Measurement of serum prostate-specific antigen (PSA) and digital rectal examination (DRE) are commonly used for prostate cancer screening. Clinicians have been advised to avoid measuring serum PSA after DRE because of the possibility of s